Daaweynta shucaaca ee la-dhexgeliyo (IFRT) waa erey loo isticmaalo bixinta shucaaca kaliya meelaha ay ka mid yihiin jirka ee ku lug leh lenfoma .
Tusaale ahaan, haddii lymfoma uu saameyn ku yeesho dhinaca bidix ee qoorta, IFRT waxay shucaac siin doontaa dhinaca bidix ee qoorta. Haddii lymfoma uu saameeyo laba meel sida qoorta iyo kilkisha, shucaaca ayaa la geyn doonaa labada goobood oo keliya.
Isticmaalaan iyo Faa'iidooyinka
IFRT waxaa loo isticmaalaa marka la barbardhigo daaweynta shucaaca dabaysha , taas oo bixisa shucaaca meelo badan oo jidhka ah, oo ay ka mid yihiin gobollada aan isla markiiba ku lug laheyn lymphoma.
Daaweynta shucaaca dabaysha ee ballaaran ayaa la isticmaalay sannado badan lymphoma. Inkasta oo heerka sokeeye ee xaalad gaar ah la helay, bukaanjiifka qaar ayaa kicin kara kansarka labaad ama ay waxyeello u geystaan xubnaha kale ee muhiimka ah maxaa yeelay shucaaca ayaa sidoo kale saameynaya meelaha iyo meelaha u dhow. Bukaan-socodka loo maro EFRT waxay leeyihiin heerar sareeya kansarka labaad ee qaybta jidhka soo baxa, gaar ahaan kansarka naasaha ee haweenka iyo kansarka sanbabada ee ragga.
Daraasaduhu waxay heleen waxtarkooda la midka ah ee ka shaqeynaya oo kaliya goobaha lagu lug lahaa halkii ay ka ahaan lahaayeen meel ballaadhan. Bukaannada la bartay waxay lahaayeen heerar isku mid ah oo jawaab buuxa, horumarka, dib-u-dhac iyo dhimasho. Hase yeeshee, waxa kale oo ay yeesheen waxyeelo yar oo soo kordhay sida dhiig yar, lalabbo, iyo bedelaad dhadhan.
Sababtoo ah faa'iidooyinkaas, waxaa jiray isbeddel fara badan oo IRFT ah oo loogu talagalay daaweynta shucaaca ee Hodgkin iyo Non-Hodgkin Lymphoma.
Waa kuwan xaaladaha qaarkood ee IFRT ay noqotay in la isticmaalo:
- Daaweynta lymphoma ee Hodgkin - ka dib 4 ilaa 8 wareeg oo daaweynta kiimiko ah ee marxaladda I iyo II.
- Daweynta lafdhabarta ee non-Hodgkin lymphoma - ka dib markii kiimiko lagu daaweeyo marxaladda I iyo II
- Daaweynta lymphoma lymphoma - sida daaweynta kaliya ee marxaladda I.
- Nooc kasta oo lymfoma ah marka uu jiro qiyaas ka baxsan ka dib kiimoterapiga ama aag yar oo dib-u-soo-kabasho ka dib muddada daaweynta kemotherabi.
Inta badan daaweynta ku lug leh shucaaca gudaha waxaa lagu dhammaystiraa 4 ilaa 5 asbuuc. Muddada daaweynta waxay kuxirantahay qiyaasta la bixiyay. Marka IFRT sida caadiga ah la bixiyo ka dib daweynta kiimoteraabiga, qiyaasta ayaa inta badan ku saleysan inta ay le'eg tahay cudurka ka dib daweynta kemotherabi.
La-socoshada Bogga Dhiigga Daaweynta Shucaaca iyo La-qabsiga Daaweynta Shucaaca Nodal
Xitaa meelaha yaryar ee shucaacu waxay noqdaan kuwo aad u sarreeya oo leh daaweynta shucaaca ee ku lugta leh, oo loogu talagalay oo keliya qanjirada noodhka ee asal ahaan ku jira cudurka Hodgkin. Tani waxay beddeleysaa IFRT ee cudurka Hodgkin ee xeerarka iyo xarumaha caafimaad qaarkood.
Waxaa sidoo kale jira daaweynta shucaaca ee nodal (INRT). Halka IFRT ay ka dhalatey qayb ka mid ah qanjidhada nudaha, INRT waxay diiradda saartaa oo keliya marka la eego noodarka la ballaariyay ka dib markii kiimiko lagu daaweynayo. Waxay sidoo kale isbarbardhigi kartaa tijaabooyinka leh ballaarin ballaaran iyo daaweynta shucaaca dabka.
Daaweynta la doorbido
Daaweynta la doorbiday ayaa sii wadi doonta in ay sii socoto sidaas darteed wax khasaare ah ayaa ka imaanaya unugyada caafimaadka qaba inta ay weli waxtar u yihiin lymphomas.
Hadafku waa in la dilo unugyada lymphoma oo aan ka muuqan meelaha kale si shucaac iyo saameyntiisa.
Kala hadal daaweynta shucaaca dhakhtarkaaga si aad u fahamto sida iyo sababta noocyada kala duwan ee daaweynta loo isticmaali karo kiiskaaga.
Ilaha
Magdalena Witkowska, * Agata Majchrak, iyo Piotr Smolewski. "Doorka Radiotherapy ee Hodgkin's Lymphoma: Maxaa Lagu Helay 50-kii Sannadood ee Ugu Dambeeyay?" 2015: 485071.
Daweynta shucaaca ee cudurka Hodgkin, Society Cancer Society.